Absence of antineutrophil cytoplasmic antibodies in relatives of UK patients with primary sclerosing cholangitis and ulcerative colitis

European Journal of Gastroenterology and Hepatology

Volumn 8, Issue 2, 1996, Pages 111-116

  Bansi, Devinder S ^a   Lo, Sukong ^b   Chapman, Roger W ^a   Fleming, Kenneth A ^a  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Antineutrophil cytoplasmic antibodies; Familial occurrence; Sclerosing cholangitis; Ulcerative colitis

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC MARKER; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RELATIVE; ULCERATIVE COLITIS; UNITED KINGDOM;

EID: 0029922356     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199602000-00004     Document Type: Article

References (35)

1. Chapman RW, Arborgh BM, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, et al.: Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980, 21:870-877.
2. Donaldson PT, Farrant JM, Wilkinson ML, Hayllar K, Portman BC, Williams R: Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis. Hepatology 1991, 13:129-133.
3. Chapman RW, Kelly P, Heryet A, Jewell DP, Fleming KA: Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis. Gut 1988, 29:422-427.
4. Snook JA, Chapman RW, Fleming KA, Jewell DP: Peripheral blood and portal tract lymphocytes in primary sclerosing cholangitis. J Hepatol 1989, 9:36-41.
5. Saxon A, Shanahan F, Lander C, Ganz T, Targan S: A distinct subset of antineutrophil cytoplasmic antibody is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990, 86:202-210.
6. Duerr RH, Targan SR, Landers CJ, LaRusso NF, Lindsay KL, Wiesner RH, et al: Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1991, 100:1385-1391.
7. Seibold F, Weber P, Klein R, Berg PA, Wiedmann KH: Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and ulcerative colitis. Gut 1992, 33:657-662.
8. Lo SK, Fleming KA, Chapman RW: Prevalence of antineutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique. Gut 1992, 33:1370-1375.
9. Nolle B, Specks U, Ludemann J, Rohrbach MS, DeRemee RA, Gross WL: Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener's granulomatosis. Ann Intern Med 1989, 111:28-40.
10. Broekroelofs J, Mulder AH, Nelis GF, Westerveld BD, Tervaert JW, Kallenberg CG: Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD). Relation to disease pattern and disease activity. Dig Dis Sci 1994, 3:545-549.
11. Rump JA, Worner I, Roth M, Scholmerich J, Hansch M, Peter HH: p-ANCA of undefined specificity in ulcerative colitis: correlation to disease activity and therapy. Adv Exp Med Biol 1993, 336:507-513.
12. Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan F: Antineutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrhoeal illnesses. Gastroenterology 1991, 100:1590-1596.
13. Mulder AL, Horst G, Haagsma E, Limburg P, Kleinbenker J, Kallenberg C: Prevalence and characterisation of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology 1993, 17:411-417.
14. Targan SR, Landers C, Vidrich A, Czaja AJ: High-titre antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology 1995, 108:1159-1166.
15. Haagsma EB, Mulder AHL, Gouw ASH, Hurst G, Meerman L, Sloof MJH, Kallenberg CGM: Neutrophil cytoplasmic autoantibodies after liver transplantation in patients with primary sclerosing cholangitis. J Hepatol 1993, 19:8-14.
16. Rotter JI, Shohat T, Vadheim CM: Is inflammatory bowel disease a genetic disease? In Inflammatory Bowel Diseases. Edited by Rachmilewitz D, Zimmerman J. Dordrecht, The Netherlands: Kluwer Academic: 1990:5-18.
17. Prochazka EJ, Terasaki PI, Park MS, Goldstein LI, Busuttil RW: Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med 1990, 322:1842-1844.
18. Quigley EMM, LaRusso NF, Ludwig J, MacSween RNM, Birme GG, Watkinson G: Familial occurrence of primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1983, 85:1160-1165.
19. Shanahan F, Duerr R, Rotter JI, Young H, Sutherland LR, McElree C, et al.: Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. Gastroenterology 1992, 103:456-461.
20. Seibold F, Slametschka D, Gregor M, Weber P Neutrophil autoantibodies: A genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1994, 107:532-536.
21. Reumaux D, Delecourt L, Colombel JF, Noel LH, Duthilleul P, Cortot A: Antineutrophil cytoplasmic autoantibodies in relatives of patients with ulcerative colitis (letter). Gastroenterology 1992, 103:1706.
22. Lee JCW, Lennard-Jones JE, Cambridge G: Antineutrophil antibodies in familial inflammatory bowel disease. Gastroenterology 1995, 108:428-433.
23. Monteleone G, Doldo P, Marasco R, Parrello T, Imeneo M, DeMedici A, et al.: Perinuclear neutrophil autoantibodies (ANCA) in unaffected relatives of patients with ulcerative colitis (UC). Suggestions against familial aggregation. Gut 1994, 3rd United European Gastroenterology Week:A20.
24. Truelove SC, Witts LJ: Cortisone in ulcerative colitis; final report of a therapeutic trial. BMJ 1955, 2:1041-1048.
25. Ludwig J: Surgical pathology of the syndrome of primary sclerosing cholangitis. Am J Surg Pathol 1989, 13(suppl 1):43-49.
26. Ferrante A, Thong YH: A rapid one-step procedure for purification of mononuclear and polymorphonuclear leucocytes from human blood using a modification of the Hypaque-Ficoll technique. J Immunol Methods 1978, 24:389-393.
27. Gross WL, Schmitt WH, Csernok E: Antineutrophil cytoplasmic autoantibody associated diseases: a rheumatologists perspective. Am J Kidney Dis 1991, 18:157-179.
28. Pokorny CS, Norton ID, McCaughan GW, Selby W: Antineutrophil cytoplasmic antibody: a prognostic indicator in primary sclerosing cholangitis. J Gastroenterol Hepatol 1994, 9:40-44.
29. Oudkerk Pool M, Roca M, Reumaux D, Bouma G, Salvador Pena A, Colombel JF, et al.: The value of pANCA as a serological marker for ulcerative colitis in different European regions. Eur J Gastroenterol Hepatol 1994, 6:399-403.
30. Shanahan F: Neutrophil autoantibodies in inflammatory bowel disease: are they important? Gastroenterology 1994, 107:586-589.
31. Yang H, Roller J, Toyoda H, Landers C, Tyan D, McElree C, et al: Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class 2) and subclinical (antineutrophil cytoplasmic antibodies) markers. J Clin Invest 1993, 92:1080-1084.
32. Mehal WZ, Lo SK, Wordsworth PB, Chapman RW, Fleming KA: HLA DRw52a and Dw2 are not associated with the development of antineutrophil antibody type 1 (ANCA 1) in ulcerative colitis (UC) [abstract]. Gastroenterology 1993, 104:A743.
33. Riley WJ, Maclaren NK, Krischer J, Spiller RP, Silverstein JH, Schatz DA, et al.: A prospective study of the development of diabetes in relatives of patients with insulin dependent diabetes mellitus. N Engl J Med 1990, 323:1167-1172.
34. Yang P, Jarnerot G, Danielsson D, Tysk, Lindberg E: P-ANCA in monozygotic twins with inflammatory bowel disease. Gut 1995, 36:887-890.
35. Snook JA, De-Silva HJ, Jewell DP: The association of autoimmune disorders with inflammatory bowel disease. Q J Med 1989, 72:835-840.